Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
US11479556B1 · kind B1 · utility
4Cited by
30References
106Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2019 |
| Grant date | Oct 25, 2022 |
| Priority date | — |
| Expiry date | Oct 14, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.